Header Logo

Connection

NAVAL DAVER to Interleukin-10

Back to Details
This is a "connection" page, showing publications NAVAL DAVER has written about Interleukin-10.
NAVAL DAVER
Connection Strength
0.140
Interleukin-10
  1. Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial. Lancet Oncol. 2019 11; 20(11):1544-1555.
    View in: PubMed
    Score: 0.140
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.